C. Matos, Lisbon, PT
Champalimaud Foundation Head of Imaging DepartmentAuthor Of 8 Presentations
PG 3.4
SE-032
SE-032 - 2D and 3D assessment of radiomic features stability in patients with rectal cancer (ID 54078)
SE-040
SE-040 - MRI-only radiotherapy planning for rectal cancer patients (ID 54403)
SS 2.2
SS 2.2 - Multi-exponential T2* mapping distinguishes benign from malignant lymph nodes in rectal cancer patients: an ex vivo and in vivo experiment (ID 53940)
SS 2.3
SS 2.3 - Comparison of 8 diffusion MR models to distinguish benign/malignant mesorectal lymph nodes from rectal cancer patients performed ex vivo at ultrahigh field (ID 53939)
SS 2.5
SS 2.5 - The tram track sign: a new, highly specific and reliable sign for the detection of complete response after neoadjuvant therapy in rectal cancer (ID 53938)
SS 2.8
SS 2.8 - Ulcerated scars post neoadjuvant therapy in rectal cancer: can morphologic changes and diffusion-weighted imaging restriction patterns predict a complete response? (ID 54307)
SS 9.7
SS 9.7 - Consistency of MR radiomic features on T2-weighted imaging of the liver (ID 54142)
Presenter Of 1 Presentation
PG 3.4
Moderator Of 3 Sessions
Postgraduate Course
The Auditorium
Moderators
Session Type
Postgraduate Course
Date
Tue, Jun 12, 2018
Time
14:15 - 15:45
Plenary Session
The Liffey A
Moderators
Session Type
Plenary Session
Date
Fri, Jun 15, 2018
Time
13:00 - 14:00
Plenary Session
The Liffey A
Moderators
Session Type
Plenary Session
Date
Fri, Jun 15, 2018
Time
14:15 - 15:15